Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 52 citing Vrbíková: Insulin sensitivity and b-cell function in women with polycystic ovary syndrome. (0.08 sec) 

Endothelial dysfunction in young women with polycystic ovary syndrome: …

- endojournals.org
I Tarkun, BC Arslan, Z Canturk, E Turemen, T … - Journal of Clinical …, 2004 - Endocrine Soc
Women with polycystic ovary syndrome (PCOS) carry a number of cardiovascular risk factors.
Cardiovascular morbidity is elevated even in young women with PCOS. Low-grade chronic inflammation,
reflected in elevated levels of ...
Cited by 122 - Related articles - BL Direct - All 6 versions

Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, …

- oxfordjournals.org
CJ Glueck, N Goldenberg, P Wang, M Loftspring, A … - Human Reproduction, 2004 - ESHRE
BACKGROUND: In a prospective observational study of 42 pregnancies in 39 Caucasian women (age 30 ±
4 years) with polycystic ovary syndrome (PCOS), we examined effects of metformin on maternal
insulin, insulin resistance (IR), ...
Cited by 100 - Related articles - BL Direct - All 9 versions

Insulin sensitivity in women with polycystic ovary syndrome

- endojournals.org
J VrbIkova, D Cibula, K Dvorakova, S Stanicka, … - Journal of Clinical …, 2004 - Endocrine Soc
The aim of our study was to compare insulin sensitivity in lean and obese European polycystic ovary
syndrome (PCOS) women with lean healthy women. We performed the euglycemic hyperinsulinemic clamp in
83 women with PCOS [53 lean with ...
Cited by 59 - Related articles - BL Direct - All 4 versions

Comparison of the insulin action parameters from hyperinsulinemic clamps with …

- endojournals.org
J Skrha, T Haas, G Sindelka, M Prazny, J … - Journal of Clinical …, 2004 - Endocrine Soc
The aim of this study was to compare insulin sensitivity expressed by the hyperinsulinemic clamp and
by the homeostasis model assessment (HOMA) and QUICKI indexes in subjects with various disorders
influencing insulin action. We ...
Cited by 47 - Related articles - BL Direct - All 4 versions

Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial …

- eje.org
I Tarkun, B Cetinarslan, E Turemen, T Sahin, Z … - European Journal of …, 2005 - eje.org
Results: After treatment with rosigitazone there were significant decreases in serum testosterone
(91.2±37.5 vs 56.1±21.8 ng/dl; P < 0.01) and fasting insulin concentrations (12.5±7.6 vs
8.75±4.03µU/ml; P = 0.015). ...
Cited by 42 - Related articles - All 7 versions

{beta}-Cell Function: A Key Pathological Determinant in Polycystic Ovary …

- endojournals.org
MO Goodarzi, S Erickson, SC Port, RI Jennrich, … - Journal of Clinical …, 2005 - Endocrine Soc
We report data from 60 patients with polycystic ovary syndrome (PCOS) who had undergone assessment
of insulin resistance, pancreatic ß-cell function, obesity, and androgen levels to elucidate the
complex relationships among these ...
Cited by 28 - Related articles - All 5 versions

Polycystic ovary syndrome and the metabolic syndrome


JL Sharpless - Clinical Diabetes, 2003 - Am Diabetes Assoc
As national attention is focused on the emerging epidemic of type 2 diabetes and obesity, more
energy is being directed toward earlier detection, improved therapies, and potential prevention. One
condition commonly detected in a ...
Cited by 23 - Related articles - BL Direct - All 2 versions

Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in …

- endojournals.org
G Faulds, M Ryden, I Ek, H Wahrenberg, P … - Journal of Clinical …, 2003 - Endocrine Soc
POLYCYSTIC OVARIAN SYNDROME (PCOS) is the most common endocrine disorder in women of reproductive
age (1). It is well known that PCOS women are prone to become obese and develop a number of
complications associated with ...
Cited by 21 - Related articles - BL Direct - All 4 versions

Insulin resistance in PCOS


E Diamanti-Kandarakis - Endocrine, 2006 - Springer
Polycystic ovary syndrome (PCOS) is the commonest endocrinopathy affecting women of reproductive
age, manifested with a variety of clinical signs, none of which is pathognomonic. The association of
insulin resistance and reproductive ...
Cited by 20 - Related articles - BL Direct - All 5 versions

Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary …


FR Cattrall, DL Healy - Best Practice & Research Clinical Obstetrics & …, 2004 - Elsevier
It is generally accepted that polycystic ovary syndrome (PCOS) is associated with an increased risk
of cardiovascular disease.[1., 2. and 3.] Dyslipidaemia, hypertension and diabetes are more common
in women with PCOS. [2.] Obesity, ...
Cited by 18 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google